Darren Brenner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Darren Brenner has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed El-Sohemy
University of Toronto
1 shared publication - Alaa Badawi
Public Health Risk Sciences Division, Public Health Agency of Canada, Toronto, ON, Canada
1 shared publication - Andre Villegas
Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, Guelph, ON, Canada
1 shared publication - Bibiana Garcia-Bailo
Office for Biotechnology, Genomics and Population Health, Public Health Agency of Canada, 180 Queen Street West, Toronto, M5V 3L7, Canada
1 shared publication - Jeremy Brent Richards
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada
1 shared publication - Mohamed A. Karmali
Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, Guelph, Ontario, Canada
1 shared publication
Latest Publications
- Open Access
- 14 July 2011
- Published by Springer Nature in BMC Medical Genetics
- Vol. 12 (1) , 95
Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes
Background: Type 2 diabetes mellitus (T2DM) has been linked to a state of pre-clinical chronic inflammation resulting from abnormalities in the innate immune pathway. Serum levels of pro-inflammatory cytokines and acute-phase proteins, collectively known as 'inflammatory network', are elevated in the pre-, or early, stages of T2DM and increase with disease progression. Genetic variation can affect the innate immune response to certain environmental factors, and may, therefore, determine an individual's lifetime risk of disease.Methods: We conducted a cross-sectional study in 6,720 subjects from the TwinsUK Registry to evaluate the association between 18 single nucleotide polymorphisms (SNPs) in five genes (TLR4,IL1A,IL6,TNFA, andCRP) along the innate immunity-related inflammatory pathway and biomarkers of predisposition to T2DM [fasting insulin and glucose, HDL- and LDL- cholesterols, triglycerides (TGs), amyloid-A, sensitive C-reactive protein (sCRP) and vitamin D binding protein (VDBP) and body mass index (BMI)].Results: Of 18 the SNPs examined for their association with nine metabolic phenotypes of interest, six were significantly associated with five metabolic phenotypes (Bonferroni correction,P ≤ 0.0027). Fasting insulin was associated with SNPs inIL6andTNFA, serum HDL-C with variants ofTNFAandCRPand serum sCRP level with SNPs inCRP. Cross-correlation analysis among the different metabolic factors related to risk of T2DM showed several significant associations. For example, BMI was directly correlated with glucose (r = 0.11), insulin (r = 0.15), sCRP (r = 0.23), LDL-C (r = 0.067) and TGs (r = 0.18) but inversely with HDL-C (r = -0.14). sCRP was also positively correlated (P < 0.0001) with insulin (r = 0.17), amyloid-A (r = 0.39), TGs (r = 0.26), and VDBP (r = 0.36) but inversely with HDL-C (r = -0.12).Conclusion: Genetic variants in the innate immunity pathway and its related inflammatory cascade is associated with some metabolic risk factors for T2DM; an observation that may provide a rationale for further studying their role as biomarkers for disease early risk prediction.
- 14 July 2011
- Published by Springer Nature in BMC Medical Genetics
- Vol. 12 (1) , 95
Open AccessGenetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes
Background: Type 2 diabetes mellitus (T2DM) has been linked to a state of pre-clinical chronic inflammation resulting from abnormalities in the innate immune pathway. Serum levels of pro-inflammatory cytokines and acute-phase proteins, collectively known as 'inflammatory network', are elevated in the pre-, or early, stages of T2DM and increase with disease progression. Genetic variation can affect the innate immune response to certain environmental factors, and may, therefore, determine an individual's lifetime risk of disease.Methods: We conducted a cross-sectional study in 6,720 subjects from the TwinsUK Registry to evaluate the association between 18 single nucleotide polymorphisms (SNPs) in five genes (TLR4,IL1A,IL6,TNFA, andCRP) along the innate immunity-related inflammatory pathway and biomarkers of predisposition to T2DM [fasting insulin and glucose, HDL- and LDL- cholesterols, triglycerides (TGs), amyloid-A, sensitive C-reactive protein (sCRP) and vitamin D binding protein (VDBP) and body mass index (BMI)].Results: Of 18 the SNPs examined for their association with nine metabolic phenotypes of interest, six were significantly associated with five metabolic phenotypes (Bonferroni correction,P ≤ 0.0027). Fasting insulin was associated with SNPs inIL6andTNFA, serum HDL-C with variants ofTNFAandCRPand serum sCRP level with SNPs inCRP. Cross-correlation analysis among the different metabolic factors related to risk of T2DM showed several significant associations. For example, BMI was directly correlated with glucose (r = 0.11), insulin (r = 0.15), sCRP (r = 0.23), LDL-C (r = 0.067) and TGs (r = 0.18) but inversely with HDL-C (r = -0.14). sCRP was also positively correlated (P < 0.0001) with insulin (r = 0.17), amyloid-A (r = 0.39), TGs (r = 0.26), and VDBP (r = 0.36) but inversely with HDL-C (r = -0.12).Conclusion: Genetic variants in the innate immunity pathway and its related inflammatory cascade is associated with some metabolic risk factors for T2DM; an observation that may provide a rationale for further studying their role as biomarkers for disease early risk prediction.